PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Cyclosporine-A via Suppression of Mitochondrial DNA.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30367813 ↗2018Reported benefit

Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Cyclosporine-A via Suppression of Mitochondrial DNA.

MouseEndotoxin/LPSC57BL/6Malen = n=6 per group, 24 totalIntraperitoneal2.5 mg/kg (low dose) and 25 mg/kg (high dose)15 min after lipopolysaccharide administration

Model: Lipopolysaccharide-induced acute lung injury (intraperitoneal LPS 10 mg/kg)

Both doses of cyclosporine-A reduced the lipopolysaccharide-induced rise in lung wet to dry ratio, myeloperoxidase activity, lavage total cells and neutrophils. Only the 25 mg/kg dose significantly improved the histological lung injury score and reduced lavage total protein. Plasma mitochondrial DN…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.